Drivers often notice something odd while sitting in traffic on a bright, sunny day. Beyond the glow of brake lights, some ...

How this formidable malware family is rapidly turning into a Swiss army knife for rogue nations and cybercriminals ...

Researchers detail new AI and phishing kits that steal credentials, bypass MFA, and scale attacks across major services.

The UK chancellor, Rachel Reeves, delivered a budget on Wednesday that contained few surprises, least of all the decision to freeze tax thresholds. After ruling out an income tax hike at the last ...

Startup founders who operate in "stealth mode," avoid human contact, networking, and marketing. Andrew Yeung argues this isolation, often mistaken for integrity or focus, leads to feedback starvation, ...

After an FDA rejection in May, Stealth BioTherapeutics has resubmitted a new drug application for its investigational treatment designed to treat an ultra-rare genetic disease. This is the biotech’s ...

Turtle Beach is no stranger to making high-performance gaming hardware, either through its PDP brand or its own in-house accessories. The company is perhaps best known for its gaming headsets but has ...

The B-2s, valued at roughly $2 billion a piece, are known not only for their stealth technology, but for their ability to fly long range. Its design and materials limit its ability to be detected by ...

The Turtle Beach Stealth 600 is a smashing mid-range wireless gaming headset. I wish the sound isolation was more impressive, and the lack of floating headband really grinds my gears considering ...

Israel's unique F-35I lends a critical capability to its air force and has been involved in strikes on Iran. Actions against Iran are the "most challenging" F-35s have flown, an airpower expert said.

The reveal of a black budget military project with futuristic technologies raises an important question: what else is the military funding that the public doesn’t know about? The Stealth Hawk began ...

May 29 (Reuters) - Privately held Stealth BioTherapeutics said on Thursday the U.S. Food and Drug Administration had declined to approve its therapy for an ultra-rare condition called Barth Syndrome, ...